FDA to hold public hearings on CBD in April
Food and Drug Administration (FDA) will hold public hearings on CBD in April, according to statements made by FDA Commissioner Scott Gottlieb, during a recent House Appropriations subcommittee hearing. The purpose of the public hearing will be to start the rule-making process and gather stakeholder input on how the FDA can regulate hemp-derived CBD.
In addition, FDA will form a working group of senior officials and agency experts to advise the Commissioner on regulatory options. Gottlieb affirmed Congress wants a path for regulating food and dietary supplements containing CBD. Gottlieb said, “this is not a straightforward process. There’s not a good proxy for us doing this through regulation.”
The conceptual regulatory framework includes a pharmaceutical path and a path for food products and dietary supplements. Gottlieb specifically mentions FDA approved CBD epilepsy medication, Epidiolex and wanting to maintain a motivation to study CBD for pharmaceutical products by keeping a pharmaceutical regulatory framework.
Although Gottlieb declared his attention to the complexities of regulating CBD, he recently announced his April resignation for personal reasons, almost a year after his appointment as FDA Commissioner.
McAllister Garfield, P.C. is busy advising hemp and CBD companies during this time of transition. For more information, contact McAllister Garfield today.
Related Article
August 2025 Psychedelic Law Update
Status of Colorado Model State Screening Forms For many months, DORA has been promising to release the model screening forms that will satisfy the requirements of the Natural Medicine Health Act to conduct a psilocybin healing administration session under the state regulated program. However, the models forms have not yet been finalized or released. There […]
July 2025 Psychedelic Law Update
Denver Local Natural Medicine Licenses Now Available The City of Denver is requiring a local license fornatural medicine healing centers that allow original facilitators to practice as a result of Denver City Council unanimously approvingCouncil Bill 25-0132in March. Healing centers with only clinical facilitators are exempt from the local licensing requirements. Natural medicine cultivating, manufacturing […]
June 2025 Psychedelic Law Update
NMHA System is Live with Licensing of Testing Facility – Medicine available With the licensing of the first testing facility in Colorado, the regulated natural medicine supply chain is complete and the program is fully launched for operations. The state issued a compliance tip guidance on testing. See the guidance here. McAllister Law has a list […]